Alopecia Treatment Market: By Disease Treatment (Alopecia Areata, Androgenic Alopecia, Traction Alopecia, and Others), By Drug Class (Corticosteroids, 5AR Inhibitors, Vasodilators, and Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), and Geography

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Alopecia Treatment Market size was valued at USD 8.6 Billion in 2022 and is anticipated to reach USD 21.4 Billion by 2029, growing at an 11.2% CAGR from 2023 to 2029. Alopecia is an autoimmune disorder in which hair loss and baldness have been observed in both males and females. Various drugs and treatments are marketed such as hair transplant, scalp reduction, and others that prevent alopecia, the incidence of alopecia has increased by 49.2% globally which is higher in the 20-24- and 30-34-years age group for males and females. The change in lifestyle along with rising stress levels and unbalanced diets are the major cause of hair fall which influence the alopecia treatment market demand. In addition, the increasing geriatric population and hormonal changes cause alopecia which drives the alopecia treatment market growth. The market for alopecia treatment is filled with local and international key players, increase in research and development activities accelerate the market, increasing prevalence of Type 1 diabetes, thyroid illness, and multiple sclerosis linked with genetic disorder cause hair fall issues which creates numerous opportunities in alopecia treatment market. The cost of treatment involves high medications and artificial hair transplants are expensive, also strict regulations policies regarding medications and lack of awareness among people restrain the market growth. Geographically, North America held the major alopecia treatment market share in 2022 and is expected to dominate the global alopecia treatment market report due to the increasing prevalence of auto-immune disorder in the region.

Alopecia Treatment Market Key Developments:
  • In June 2022, FDA Approves Eli Lilly and Incyte's OLUMIANT® (baricitinib) As the First and Only Systemic Medicine for Adults with Severe Alopecia Areata treatment.
  • In August 2021, Pfizer Inc. announced positive top-line results from the Phase 2b/3 ALLEGRO trial evaluating oral once-daily ritlecitinib in patients with alopecia areata. Ritlecitinib 50 mg and 30 mg achieved the primary efficacy endpoint of the study, namely the proportion of patients with less than or equal to 20 percent scalp hair loss after six months of treatment versus placebo.

Global Alopecia Treatment Market Summary

Study Period

2023-29

Base Year

2022

CAGR

11.2%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Alopecia Treatment Market Dynamics

The increasing prevalence of autoimmune disorders across the world is the major market driver in the Alopecia Treatment Market during the forecast period. The autoimmune disorder is caused due to unhealthy diet and improper lifestyle, 60% of the population suffers from thin hair, with pattern hair loss in both males and females which demands effective treatment options to prevent alopecia. In addition, increasing spending on healthcare infrastructure accelerates the development of treatment options and raises awareness about hair regrowth and treatment alternatives. The genetic factor is directly involved in hair fall, the person suffers from type 1 diabetes, and hypertension is linked with the patient or family. Hence, this will drive the global market growth at a significant rate.

Key Features of the Reports

  • The alopecia treatment market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Alopecia Treatment Market Segmentation

By Disease Treatment
  • Alopecia Areata
  • Androgenic Alopecia
  • Traction Alopecia
  • Others
By Drug Class
  • Corticosteroids
  • 5AR Inhibitors
  • Vasodilators
  • Others
By End User
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
By Geography
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa (MEA)

Frequently Asked Questions

The alopecia treatment market size was valued at usd 8.6 billion in 2022 and is anticipated to reach usd 21.4 billion by 2029

The alopecia treatment market is poised to grow at a significant cagr of 11.2% from 2023 to 2029.

The leading players in the alopecia treatment market are Johnson & Johnson Services, Inc., Merck & Co. Inc., Cipla Limited, Sun Pharmaceuticals Industries Ltd., Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc., Aurobindo Pharma, and Mylan N.V. (Viatris Inc.)

Historic years considered for the market study are 2018 through 2022, 2022 is considered as the base year for market estimation, and Seven years forecast is presented from 2023 – 2029.

1.Executive Summary
2.Global Alopecia Treatment Market Introduction 
2.1.Global Alopecia Treatment Market  - Taxonomy
2.2.Global Alopecia Treatment Market  - Definitions
2.2.1.Cell Type
2.2.2.Drug Class
2.2.3.End User
2.2.4.Region
3.Global Alopecia Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Alopecia Treatment Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Alopecia Treatment Market  By Cell Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Alopecia Areata
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Androgenic Alopecia
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Traction Alopecia
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Alopecia Treatment Market  By Drug Class, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Corticosteroids
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. 5AR Inhibitors
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Vasodilators
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Alopecia Treatment Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Retail Pharmacy
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Hospital Pharmacy
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Pharmacy
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Alopecia Treatment Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Alopecia Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Cell Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Alopecia Areata
9.1.2.Androgenic Alopecia
9.1.3.Traction Alopecia
9.1.4.Others
9.2.  Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Corticosteroids
9.2.2.5AR Inhibitors
9.2.3.Vasodilators
9.2.4.Others
9.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Retail Pharmacy
9.3.2.Hospital Pharmacy
9.3.3.Online Pharmacy
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Alopecia Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Cell Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Alopecia Areata
10.1.2.Androgenic Alopecia
10.1.3.Traction Alopecia
10.1.4.Others
10.2.  Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Corticosteroids
10.2.2.5AR Inhibitors
10.2.3.Vasodilators
10.2.4.Others
10.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Retail Pharmacy
10.3.2.Hospital Pharmacy
10.3.3.Online Pharmacy
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
10.4.7.
11.Asia Pacific (APAC) Alopecia Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Cell Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Alopecia Areata
11.1.2.Androgenic Alopecia
11.1.3.Traction Alopecia
11.1.4.Others
11.2.  Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Corticosteroids
11.2.2.5AR Inhibitors
11.2.3.Vasodilators
11.2.4.Others
11.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Retail Pharmacy
11.3.2.Hospital Pharmacy
11.3.3.Online Pharmacy
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Alopecia Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Cell Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Alopecia Areata
12.1.2.Androgenic Alopecia
12.1.3.Traction Alopecia
12.1.4.Others
12.2.  Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Corticosteroids
12.2.2.5AR Inhibitors
12.2.3.Vasodilators
12.2.4.Others
12.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Retail Pharmacy
12.3.2.Hospital Pharmacy
12.3.3.Online Pharmacy
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Alopecia Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Cell Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Alopecia Areata
13.1.2.Androgenic Alopecia
13.1.3.Traction Alopecia
13.1.4.Others
13.2.  Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Corticosteroids
13.2.2.5AR Inhibitors
13.2.3.Vasodilators
13.2.4.Others
13.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Retail Pharmacy
13.3.2.Hospital Pharmacy
13.3.3.Online Pharmacy
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Cellmid Ltd. (Australia)
14.2.2.Cipla Ltd. (India)
14.2.3.Reddys Laboratories Ltd. (India)
14.2.4.Johnson & Johnson Services, Inc. (U.S)
14.2.5.Merck & Co., Inc. (U.S)
14.2.6.Phyto Ales Group (France)
14.2.7.Shiseido Co., Ltd.(Japan)
14.2.8.Sun Pharmaceutical Industries Ltd. (India)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Cellmid Ltd. (Australia)
  • Cipla Ltd. (India)
  • Reddys Laboratories Ltd. (India)
  • Johnson & Johnson Services, Inc. (U.S)
  • Merck & Co., Inc. (U.S)
  • Phyto Ales Group (France)
  • Shiseido Co., Ltd.(Japan)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Taisho Pharmaceutical Holdings Co., Ltd (Japan)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • The Himalaya Drug Company (India)
  • Vitabiotics (U.K)